Managed Healthcare Executive1d
FDA Sets Review Date for Linvoseltamab for Multiple Myeloma
The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...
Prince William's flying instructor dies aged 47 after 'years of toxic helicopter fumes'
Prince William's flying instructor has passed away aged 47. Flight Sergeant Zach Stubbings died after battling multiple ...
Prince William's ex-flying teacher dies aged just 47 after ‘years of inhaling helicopter fumes’
Flight Sergeant Zach Stubbings, a flying instructor who trained Prince William when he was based at RAF Valley in Anglesey from 2010 to 2013, has tragically died of cancer aged 47 ...
Opna Bio Receives Orphan Drug Designation for OPN-6602, an Oral EP300/CBP Bromodomain Inhibitor, for Multiple Myeloma
Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the ...
Oncology Nurse Advisor2d
Possible Prognostic Factors Identified for Newly Diagnosed Multiple Myeloma
Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.
Targeted Oncology2h
Mushtaq Examines Long-Term Toxicities of CAR T-Cell Therapy in Multiple Myeloma
During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...
coastcommunitynews11d
The battle against myeloma
The Central Coast Myeloma Support Group (CCMSG) is continuing its quest to support cancer patients in the region. Myeloma is a specific form of cancer of ...
Pharmabiz1d
CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4
CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4: Shanghai, China Tuesday, February 11, 2025, 18:00 Hrs [IST] CA ...
Carsgen's First Enrolled Subject In The THANK-U Plustm Platform-Based Allogeneic CAR-T Trial Achieves Scr At Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first ...